Product Platforms - Tuesday 29 October 2019

Please select the product platform you wish to view

11:00 - 11:20

Changing the paradigm for treatment intensification; combination therapy in type 2 diabetes (T2D)

The clinical benefits of IDegLira in DUAL VII™ were achieved while using a simple regimen with fewer injections and dose adjustments compared with basal–bolus therapy. This session will include: The definition and need for insulin intensification in patients with T2D The complementing benefits of insulin and GLP1-RA therapy in patients with T2D The available clinical…

*This is a promotional symposium organised and funded by Novo Nordisk. Prescribing information for all relevant products will be made available during the meeting

Medical Affairs Manager Insulin, Novo Nordisk
11:30 - 11:50

Introducing Better Living – empowering people to take charge of their Type 2 diabetes

An introduction to the Better Living materials which help empower people to take charge of their Type 2 diabetes. Learning outcomes: To see what Better Living has on offer for people living with Type 2 diabetes

*This session has been organised and funded by Takeda UK Ltd

Medical Science Liaison, Diabetes, Takeda UK Ltd
14:10 - 14:30

Thinking Beyond Sugar when Managing Diabetes

Managing glycemic control in a person with diabetes is only one aspect of comprehensive diabetes management. This symposium will provide clinicians with a summary of key recommendations that they can integrate into practice to reduce risk of complications in people with diabetes. These recommendations will the importance of immunization, cardiovascular risk reduction and other practical…

Dr David Strain
Senior Clinical Lecturer, Diabetes and Vascular Research Centre, University of Exeter Medical School
14:40 - 15:00

Introducing the new Omnipod DASH™ Insulin Management System

This session will provide introduction to Insulet and a practical overview of the new Omnipod DASH™ System. Learning outcomes: Understand the benefits of the Omnipod DASH™ System See a demonstration of the Omnipod DASH™ System Understand the data behind the benefits Overview of the Omnipod® Support Programme INS-ODS-10-2019-00026v1

Healthcare Professionals who manage people on insulin pump therapy
17:00 - 17:20

Are biosimilars interchangeable? Ask the experts

Dr. Kevin Fernando and Su Down will answer the questions following the earlier session on biosimilars in the Main Theatre.

*This session is organised and remunerated by Mylan

Susan Down
Nurse Consultant Diabetes, Somerset Primary Care Trust and Yeovil District Hospital NHS Foundation Trust
GP Partner & Medical Education & Scottish Lead, North Berwick Health Centre, GPwSI Diabetes, Primary Care Diabetes Society
11:00 - 11:20

Unveiling a new era in diabetes foot ulcer care: improving outcomes and saving costs

Learning outcomes: NEW NICE Guidance for treating diabetes foot ulcers What this means for patients, clinicians and health organisations How to implement NICE Guidance into clinical practice

FCPodM FFPM RCPS(Glas), National Diabetes Foot Specialist, Urgo Medical
11:30 - 11:50

When to include an orthotist in Diabetic Foot Management

A focused look into the information that should be provided on a referral into orthotics and when is the appropriate time to make a referral. How the orthotist will assess and treat each patient based on individual risk and a brief overview of the orthoses available. Learning outcomes: When to refer What information to include…

Senior Orthotist, Halo Medical
Clinical Development and Training Manager, Halo Medical
11:30 - 11:50

Professional Blinded CGM in Type 1 and Type 2 Patients in the Community and Primary Care Setting

Come along and join this session to learn more about the newest innovation in blinded CGM. Understand how blinded CGM can facilitate in optimal treatment decisions, by providing a comprehensive understanding of glucose profiles to improve health outcomes. Also learn and understand how to use the technology and set up a service in community and…

NDT EMEA Marketing, Medtronic
13:40 - 14:00

The changing world of diabetes nurse education

This session outlines the rapidly changing world of print and online diabetes nurse education. It highlights the question purchasers of healthcare education should be asking to ensure value for money and quality provision. Current analytics and trends will be outlined to show how print and online education is adapting to meet the demands of nurse…

Senior Nurse Editor, RCNi (Part of the Royal College of Nursing)
14:10 - 14:30
14:40 - 15:00

Transforming basal insulin management with JAZZ DoseCoach

The UK’s first basal insulin advisor with integrated blood glucose meter for type 2 patients on once daily basal insulin only, will be available from Autumn 2019. Designed to assist in the self-adjustment of basal insulin dosing, the JAZZ DoseCoach could help tens of thousands of patients who struggle with the complexities of basal insulin…

National Sales Manager, AgaMatrix Europe Ltd.
17:00 - 17:20

The T2Day Programme LIVE! at Diabetes Professional Care

Sessions sponsored by the Boehringer Ingelheim and Lilly Diabetes Alliance Prescribing and adverse event reporting information is available at: Join us for T2Day LIVE! with host Dr Amrit Lamba and our expert guests, clinical psychologist, Dr Jen Bateman and obesity expert and GP, Dr Matt Capehorn as they discuss: How to start the discussion…

GP London
Clinical Psychologist, London
GPwSI Obesity and Diabetes Management, Rotherham
11:00 - 11:20

The Next generation of dry eye drops

The session will discuss the challenges dry eye disease can cause your diabetic patients, we will also discuss a new medical option for relieving your patients dry eye symptoms.

National Sales Manager, VISUfarma
11:30 - 11:50

What’s new in diabetic retinopathy diagnosis & treatment?

Nurse Consultant, Honorary Teaching Fellow, Nurse Consultant, Honorary Teaching Fellow
13:40 - 14:00

Common presentations and management of ocular surface disease in diabetic patients

Discussion around the common presentations and the management of ocular surface disease in diabetic patients. Learning outcomes: Presenting symptoms indicative of ocular surface disease The associated objective clinical findings seen by an ophthalmic professional Common therapeutic/management options typically employed

Consultant Ophthalmic Surgeon, Medical Lead, Scope Ophthalmics
11:00 - 11:25

Zero-carb rice, noodle and pasta – the new plant-based food for diabetics

Product Development Manager, Diabetar
Pharmacist & Director, Diabetar